Equities

American Aires Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

American Aires Inc

Actions
  • Price (EUR)0.0097
  • Today's Change0.010 / 9,600.00%
  • Shares traded1.00k
  • 1 Year change-90.85%
  • Beta-0.8313
Data delayed at least 15 minutes, as of Feb 17 2026 07:04 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

American Aires Inc. is a Canada-based nanotechnology company. The Company is engaged in the business of production, distribution and sales of electromagnetic protection devices. The Company is selling a line of patented silicon-based resonator products that optimize electromagnetic field (EMF) environments to support health and well-being. Its Lifetune products diffract EMF radiation emitted by consumer electronic devices such as cellphones, computers, baby monitors, and Wi-Fi, including the more high-speed 5G networks.

  • Revenue in CAD (TTM)27.37m
  • Net income in CAD-9.49m
  • Incorporated2012
  • Employees--
  • Location
    American Aires Inc100, 400 Applewood CrescentVAUGHAN L4K 0C3CanadaCAN
  • Phone+1 (647) 404-4416
  • Websitehttps://www.airestech.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.